查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球糖尿病足溃疡市场——2023-2030 年
市场调查报告书
商品编码
1279711

全球糖尿病足溃疡市场——2023-2030 年

Global Diabetic Foot Ulcer Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球糖尿病足溃疡市场预计将以有利可图的速度增长，到 2022 年将达到 58.127 亿美元，到 2030 年将达到 93.06 亿美元。 在预测期内（2023-2030 年），糖尿病足溃疡市场预计将以 6.2% 的复合年增长率增长。 糖尿病足溃疡是糖尿病控制不佳的最常见后果之一。 血糖控制不佳、潜在的神经病变、外周血管疾病或足部护理不当是糖尿病足溃疡的常见原因。

糖尿病足溃疡是糖尿病患者面临的最严重的问题之一，因为身体癒合伤口的能力严重受损。 通常，患者的腿会酸痛，并在该特定位置迅速腐烂并产生传染性细菌。

市场动态

糖尿病足溃疡的患病率增加

糖尿病最严重、最严重的后果之一就是糖尿病足溃疡。 随着糖尿病患病率的增加，问题的数量也在增加。 有许多因素会增加糖尿病足溃疡的发病率，包括年龄增长、久坐不动的生活方式和糖尿病病程延长。

治疗技术进步

最新的手机可以拍摄与商用数码相机相当的高分辨率 DFU 图像。 目前，许多患者使用手机图片自行管理 DFU。 此外，还有部分患者携带照片到足科进行DFU治疗的跟进，定期观察伤口的进展情况。

患者还可以在线或将图像作为电子邮件附件发送给足部护理提供者。 儘管目前很难在不违反保密规定的情况下安全地共享此类临床信息，但广泛使用手机照片来自我监测 DFU 进展可能是未来足部护理的重要一步。

糖尿病足溃疡的治疗费用昂贵

糖尿病足溃疡可能需要长期的强化治疗，包括伤口敷料、药物治疗和频繁监测。 这种延长的治疗期可能导致治疗费用增加。 糖尿病足溃疡的治疗通常需要涉及多位医疗保健专业人员的多学科方法，包括足病医生、伤口护理专家、内分泌学家和血管外科医生。 在不同的医疗保健提供者之间协调护理会增加总成本。

COVID-19 影响分析

COVID-19 大流行严重扰乱了全球 DFU 治疗。 延迟评估溃疡可能会对 DFU 癒合产生不利影响并导致截肢。

在大流行期间，电话和视频诊所帮助医生解决了一些与患者在 COVID-19 封锁期间无法就诊有关的担忧。 在科学界，构建人工智能 (AI) 算法以通过虚拟诊所改善患者护理的尝试得到了时尚前沿的支持。

俄乌衝突分析

乌克兰有成千上万的人由于无法获得足够的医疗保健服务而患上糖尿病足溃疡，这使他们面临截肢的巨大风险。 未能解决与慢性溃疡和截肢相关的障碍可能会损害乌克兰个人和公众的健康。

加强初级和远程护理、教导个人自我护理以及为糖尿病足护理提供适当的用品有可能显着减少截肢、残疾和死亡率。 在乌克兰和其他衝突地区，充分的糖尿病足护理对于当地居民的健康和受影响国家在危机后的恢復至关重要。

内容

第一章调查方法及范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品类型分类的摘要
  • 按溃疡类型分类的片段
  • 最终用户的片段
  • 区域摘要

第四章市场动态

  • 影响因素
    • 主持人
      • 糖尿病足溃疡的患病率增加
    • 约束因素
      • 糖尿病足溃疡的高昂治疗费用
    • 机会
      • 治疗方案的技术进步
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法律法规分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • COVID-19 期间的情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 伤口敷料
  • 生物製品
  • 其他

第 8 章按溃疡类型

  • 神经性溃疡
  • 神经/缺血性溃疡

第 9 章最终用户

  • 医院
  • 医务室
  • 门诊手术中心
  • 家庭护理

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第12章公司简介

  • ConvaTec Inc
  • Acelity LP Inc
  • 3M Healthcare
  • Organogenesis Inc
  • Coloplast Corp
  • Smith & Nephew Plc
  • B Braun Melsungen AG
  • Medline Industries Inc
  • Medtronic
  • Molnlycke Healthcare AB

第13章 附录

简介目录
Product Code: PH20

Market Overview

The global diabetic foot ulcers market reached US$ 5,812.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 9,300.6 million by 2030. The diabetic foot ulcers market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030). Diabetic foot ulcers are one of the most prevalent consequences in persons with poorly managed diabetes mellitus. Inadequate glycemic management, underlying neuropathy, peripheral vascular disease, or inadequate foot care are common causes of diabetic foot ulcers.

Diabetic foot ulcers are one of the most serious consequences that diabetics confront since the body's wound healing capacity has been greatly diminished. It is the creation of a wound, generally in the patient's foot, which decomposes quickly and leads to the generation of infectious germs in that specific location.

Market Dynamics

Increase in the Prevalence Of Diabetic Foot Ulcers

One of the most serious and severe consequences of diabetes is diabetic foot ulcer. As the prevalence of disease increases, so do the number of problems. Various variables, including rising age, sedentary lifestyle, and longer duration of diabetes mellitus, have all contributed to an increase in the occurrence of diabetic foot ulcers.

Technological Advancements In Treatment Options

Newer mobile phones can take high-resolution DFU images that are equivalent to those taken by commercial digital cameras. Many patients currently self-monitor their DFUs using cell phone photographs. Some patients painstakingly bring these photographs to foot clinics throughout their follow-up appointments for DFU therapy to serially track their wound development.

Patients occasionally send images to footcare providers online or as email attachments. Although the safety difficulties associated with the secure sharing of such clinical information without breaching confidentiality are currently hard, the widespread use of mobile phone photography for self-monitoring of DFU development may transform future foot care.

High Cost For Treatment Of Diabetic Foot Ulcers

Diabetic foot ulcers may need long-term and intense treatment, such as wound dressings, medicines, and frequent monitoring. This prolonged duration may lead to increased treatment expenses. Diabetic foot ulcer treatment often entails a multidisciplinary approach including several healthcare experts such as podiatrists, wound care specialists, endocrinologists, and vascular surgeons. Coordination of care among various providers may increase total costs.

COVID-19 Impact Analysis

The COVID-19 pandemic caused significant hurdles in DFU treatment over the world. Delays in ulcer evaluations may have a negative impact on DFU healing, potentially leading to amputations.

During the pandemic, telephone and video clinics assisted physicians in addressing some of the concerns connected to patients' incapacity to attend medical clinics during the COVID-19 lock-down period. Attempts by the scientific community to build artificial intelligence (AI) algorithms to improve patient care through virtual clinics gained traction in response to the epidemic.

Russia- Ukraine Conflcit Analysis

Due to the country's inadequate access to healthcare services, thousands of individuals in Ukraine suffer from diabetic foot ulcers and are consequently at significant risk of lower limb amputation. Individual and public health in Ukraine may suffer if the handicap associated with chronic ulcers and amputations is not addressed.

Strengthening primary and remote care, teaching individuals on self-care, and providing appropriate supplies for diabetic foot treatment have the potential to significantly reduce amputations, disability, and mortality. Adequate diabetic foot care in Ukraine and other conflict-torn regions is critical for the health of the local population and the ability of affected countries to recover after the crisis.

Segment Analysis

The Neuropathic Segment Is Expected To Have The Market Share Of Around 46.5% Over The Forecast Period.

Neuropathic ulcers are the most prevalent form of ulcer encountered in patients. As a result, this sector is dominated in the market in this category. This kind of disease is the most difficult to manage since it causes significant pain and agony to the individual; as a result, the usage of medications increases, helping to raise the revenue return for the diabetic foot ulcer treatment market.

Neuropathic ulcers arise when a patient with impaired peripheral nervous system neurological function has pressure sites that induce ulceration via the epidermal and dermal tissue layers. This is a frequent ailment that affects the foot and occasionally other sections of the body.

Geographical Analysis

North America is Expected to be the Dominating Region During The Forecast Period.

The North America region holds the largest share of the global diabetic foot ulcers market accounting for around 37.7% in the forecast period. This is owing the large number of diabetic patients and adequate healthcare facilities in this region. Also, North America also has lengthy R&D facilities and approval periods. The country also contains cutting-edge biologics and wound care equipments for the treatment of these ulcers.

Competitive Landscape

The major global players include: ConvaTec Inc, Acelity LP Inc, 3M Healthcare, Organogenesis Inc, Coloplast Corp Smith & Nephew Plc, B Braun Melsungen AG Medline Industries Inc, Medtronic, Molnlycke Healthcare AB and others.

  • Why Purchase the Report?
  • To visualize the global diabetic foot ulcers market segmentation based on the product type, ulcer type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global diabetic foot ulcers market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global diabetic foot ulcers market report would provide approximately 92 tables, 108 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Ulcer Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased prevalence of diabetic foot ulcers
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of treatment for Diabetic foot ulcers
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements in treatment options
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Wound Care Dressing
  • 7.2. Biologics
  • 7.3. Others

8. By Ulcer Type

  • 8.1. Neuropathic Ulcers
  • 8.2. Neuro-Ischemic Ulcers

9. By End User

  • 9.1. Hospitals
  • 9.2. Clinics
  • 9.3. Ambulatory Surgical Center
  • 9.4. Homecare Setting

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ulcer Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ConvaTec Inc
  • 12.2. Acelity LP Inc
  • 12.3. 3M Healthcare
  • 12.4. Organogenesis Inc
  • 12.5. Coloplast Corp
  • 12.6. Smith & Nephew Plc
  • 12.7. B Braun Melsungen AG
  • 12.8. Medline Industries Inc
  • 12.9. Medtronic
  • 12.10. Molnlycke Healthcare AB

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us